List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 922 studies with search of: "Gemcitabine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Cisplatin;   Drug: Gemcitabine;   Drug: PF-3512676;   Drug: Cisplatin;   Drug: Gemcitabine + Cisplatin
2 Recruiting Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC
Condition: Non-Small-Cell Lung Cancer
Interventions: Drug: Docetaxel;   Drug: Gemcitabine;   Drug: Gemcitabine
3 Completed Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Vinorelbine;   Drug: Gemcitabine;   Drug: Docetaxel;   Drug: Gemcitabine
4 Recruiting Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Drug: Gemcitabine;   Drug: Erlotinib;   Drug: Oxaliplatin
5 Recruiting Lag-3 and Gemcitabine for Treatment of Advanced Pancreas Cancer
Condition: Pancreatic Neoplasms
Interventions: Drug: Gemcitabine;   Drug: LAG-3 and Gemcitabine;   Drug: LAG-3 and gemcitabine;   Drug: LAG-3 and gemcitabine;   Drug: LAG-3 and gemcitabine
6 Recruiting A Randomized Study of Amplimexon With Gemcitabine in Pancreatic Cancer
Condition: Pancreatic Neoplasms
Interventions: Drug: imexon + gemcitabine;   Drug: imexon placebo + gemcitabine
7 Completed EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas
Conditions: Adenocarcinoma;   Metastasis;   Pancreas Neoplasms
Interventions: Drug: Gemcitabine alone;   Drug: EndoTAG-1 and Gemcitabine;   Drug: EndoTAG-1 and Gemcitabine;   Drug: EndoTAG-1 and Gemcitabine
8 Suspended A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: placebo + gemcitabine + erlotinib;   Drug: Placebo + gemcitabine;   Drug: calcitriol + gemcitabine;   Drug: calcitriol + gemcitabine + erlotinib
9 Recruiting GEM vs GEM+TS-1 for Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: gemcitabine + S-1;   Drug: gemcitabine
10 Active, not recruiting Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.
Condition: Carcinoma, Pancreatic Ductal
Interventions: Drug: AG-013736;   Drug: Gemcitabine;   Drug: Gemcitabine;   Drug: placebo
11 Recruiting MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer
Conditions: Pancreatic Cancer;   Pancreatic Adenocarcinoma
Interventions: Drug: MK-0646;   Drug: Gemcitabine;   Drug: Erlotinib
12 Active, not recruiting Open-Label Study of CS1008 for Subjects With Untreated and Unresectable Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: CS-1008 (humanized anti-DR5 antibody) plus gemcitabine;   Drug: CS-1008 + gemcitabine,
13 Recruiting Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Gemcitabine plus TS-1;   Drug: TS-1;   Drug: Gemcitabine
14 Recruiting First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Gemcitabine + Sunitinib;   Drug: Gemcitabine
15 Not yet recruiting Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid Tumors
Condition: Solid Tumor
Interventions: Drug: ABT-263;   Drug: gemcitabine
16 Recruiting Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Condition: Bladder Cancer
Interventions: Drug: Gemcitabine, Cisplatin;   Drug: Gemcitabine, Cisplatin and Cetuximab
17 Recruiting Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With Gemzar
Condition: Pancreatic Cancer Stage IVA
Interventions: Drug: Gemcitabine, docetaxel, and capecitabine;   Radiation: Radiation therapy with gemcitabine
18 Recruiting A Phase I/Expansion Study of Dasatinib
Conditions: Refractory Solid Tumors;   Pancreatic Adenocarcinoma
Interventions: Drug: gemcitabine;   Drug: dasatinib;   Drug: gemcitabine;   Drug: dasatinib
19 Recruiting Gemcitabine and Docetaxel With Or Without Bevacizumab in Leiomyosarcoma, Malignant Fibrous Histiocytoma and Angiosarcoma
Conditions: Sarcoma;   Leiomyosarcoma;   Malignant Fibrous;   Histiocytoma;   Angiosarcoma
Interventions: Drug: gemcitabine and docetaxel with bevacizumab;   Drug: gemcitabine and docetaxel without bevacizumab
20 Recruiting Gemcitabine and Dasatinib in Advanced Solid Tumors
Conditions: Advanced Cancer;   Solid Tumors
Interventions: Drug: Dasatinib;   Drug: Gemcitabine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services